[1]魏小敏,王丽丽,刘海霞,等.丹参素通过STAT3/JAK2/SOCS1信号通路在妊娠期糖尿病干预中的作用机制研究[J].陕西医学杂志,2023,52(5):508-512.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.003]
　WEI Xiaomin,WANG Lili,LIU Haixia,et al.Mechanism of danshensu in gestational diabetes mellitus through STAT3/JAK2/SOCS1 signaling pathway[J].,2023,52(5):508-512.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.003]
点击复制

丹参素通过STAT3/JAK2/SOCS1信号通路在妊娠期糖尿病干预中的作用机制研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年5期
页码:
508-512
栏目:
基础研究
出版日期:
2023-05-05

文章信息/Info

Title:
Mechanism of danshensu in gestational diabetes mellitus through STAT3/JAK2/SOCS1 signaling pathway
作者:
魏小敏; 王丽丽; 刘海霞; 杨玉侠; 宋志慧
(唐山市妇幼保健院产科,河北 唐山063000)
Author(s):
WEI Xiaomin; WANG Lili; LIU Haixia; YANG Yuxia; SONG Zhihui
(Department of Obstetrics,Tangshan Maternal and Child Health Hospital,Tangshan 063000,China)
关键词:
丹参素;  妊娠期糖尿病;  肾脏;  组织损伤;  转录激活;  STAT3/JAK2/SOCS1信号通路
Keywords:
Danshensu;  Gestational diabetes mellitus;  Kidney;  Tissue damage;  Transcription activation;  STAT3/JAK2/SOCS1 signaling pathway
分类号:
R 714.256
DOI:
DOI:10.3969/j.issn.1000-7377.2023.05.003
文献标志码:
A
摘要:
目的:探究不同剂量丹参素对妊娠期糖尿病模型大鼠肾脏的影响及对STAT3/JAK2/SOCS1信号通路分子的干预作用。方法:对SPF级怀孕SD大鼠进行链脲佐菌素(STZ)注射构建妊娠期糖尿病模型,将大鼠随机分为对照组(n=10)、模型组(n=10)、厄贝沙坦组(n=10),丹参素低剂量组(n=10)、丹参素中剂量组(n=10)和丹参素高剂量组(n=10),造模成功后各治疗组分别给予厄贝沙坦[10 mg/(kg·d)]及低[10 mg/(kg·d)、中[15 mg/(kg·d)]、高[20 mg/(kg·d)]剂量的丹参素灌胃7 d。HE染色观察肾脏组织病理变化; 大生化检测血清肌酐(Scr)、血尿素氮(BUN)、尿蛋白,血糖仪检测空腹血糖,通过qPCR和Western blot检测肾脏组织中信号传感器和转录激活剂 3(STAT3)、酪氨酸蛋白激酶2(JAK2)、抑制细胞因子信号 1(SOCS1)的mRNA和蛋白表达水平。结果:丹参素能显著降低妊娠期糖尿病大鼠肾脏损伤; 降低外周血Scr、BUN、尿蛋白和空腹血糖水平,并且显著抑制STAT3、JAK2和SOCS1的mRNA和蛋白表达水平(均P<0.01)。结论:丹参素可以降低妊娠期糖尿病大鼠肾脏损伤,其机制可能与抑制STAT3/JAK2/SOCS1信号通路有关。
Abstract:
Objective:To explore the effect of different doses of danshensu on the kidneys of gestational diabetes model rats and its intervention on STAT3/JAK2/SOCS1 signaling pathway molecules.Methods:A model of gestational diabetes mellitus was established in SPF pregnant SD rats by STZ injection.The rats were randomly divided into control group(n=10),model group(n=10)and irbesartan group(n=10),danshensu low-dose group(n=10),danshensu medium-dose group(n=10)and danshensu high-dose group(n=10).After successful modeling,each treatment group was given irbesartan 10 mg/(kg·d)and low [10 mg/(kg·d)],medium [15 mg/(kg·d)]and high [20 mg/(kg·d)]doses of danshensu by gavage for 7 days.The pathological changes were detected in the kidney tissue of the rats in each group by HE staining.Serum creatinine(Scr),blood urea nitrogen(BUN),urine protein were detected by macrobiochemistry,fasting blood glucose was detected by blood glucose meter.Western blot and qPCR were used to detect signal transducer and activator of transcription 3(STAT3),Janus kinase 2(JAK2),suppressor of cytokine signaling 1(SOCS1)mRNA and protein expression levels.Results:Danshensu could significantly reduce kidney damage in gestational diabetes mellitus and decrease the levels of Scr,BUN,urine protein and fasting blood glucose in peripheral blood,and significantly inhibit the mRNA and protein expression levels of STAT3,JAK2 and SOCS1(all P<0.01).Conclusion:Danshensu can reduce kidney damage in gestational diabetic rats,and its mechanism may be related to the inhibition of STAT3/JAK2/SOCS1 signaling pathway.

参考文献/References:

[1] Michelle L,Asha R.Gestational diabetes:Overview with emphasis on medical management[J].Int J Environ Res Public Health,2020,17(24):9573.
[2] 李 琳,马红侠.血清25羟维生素D与肥胖/超重糖尿病患者合并甲状腺功能亢进相关性研究[J].陕西医学杂志,2022,51(1):70-72.
[3] Lynn RM,Paul GT.Gestational diabetes:Diagnosis,classification,and clinical care[J].Obstet Gynecol Clin North Am,2017,44(2):207-217.
[4] Emilyn UA,Therriz PM,Grace C,et al.Gestational diabetes mellitus:A harbinger of the vicious cycle of diabetes[J].Int J Mol Sci,2020,21(14):5003.
[5] Penglong C,Shuxiang W,Jianying J,et al.Risk factors and management of gestational diabetes [J].Cell Biochem Biophys,2015,71(2):689-694.
[6] Tian W,Cuiting L,Bing H,et al.Neuroprotective effects of danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo[J].BMC Complement Med Ther,2020,20(1):20.
[7] Chen Y,Hua D,Qing CW,et al.Danshensu attenuates cisplatin-induced nephrotoxicity through activation of Nrf2 pathway and inhibition of NF-κB[J].Biomed Pharmacother,2021,142:111995.
[8] Jin JJ,Mo XM,Liu JF,et al.Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis[J].Eur J Pharmacol,2020,868:172881.
[9] Ye F,Jiafa R,Yuan G,et al.Wnt/β-catenin-promoted macrophage alternative activation contributes to kidney fibrosis[J].J Am Soc Nephrol,2018,29(1):182-193.
[10] Chao Z,Lan H,Wu L,et al.Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice[J].Cell Death Dis,2019,10(11):848.
[11] 都 燕,任 娟,罗苗苗.肌醇和维生素B、D对妊娠糖尿病小鼠炎症及脂代谢的影响及机制探讨[J].陕西医学杂志,2022,51(2):159-163.
[12] 苟 芳,张红军,王 洁,等.黄连解毒汤通过抑制TGF-β信号通路减轻2型糖尿病大鼠肝脂肪变性和纤维化研究[J].陕西中医,2022,43(2):170-176.
[13] Ponnusamy S.Gestational diabetes:Opportunities for improving maternal and child health[J].Lancet Diabetes Endocrinol,2020,8(9):793-800.
[14] Chiefari E,Arcidiacono B,Foti D,et al.Gestational diabetes mellitus:An updated overview [J].J Endocrinol Invest,2017,40(9):899-909.
[15] Emma CJ,Fiona CD,Jane EN,et al.Gestational diabetes mellitus:Mechanisms,treatment,and complications[J].Trends Endocrinol Metab,2018,29(11):743-754.
[16] Xu ZX,Ke T,Zhang YF,et al.Danshensu inhibits the IL-1β-induced inflammatory response in chondrocytes and osteoarthritis possibly via suppressing NF-κB signaling pathway[J].Mol Med,2021,27(1):80.
[17] Bharath K,Lin SH,Mahalakshmi B,et al.Sodium danshensu inhibits oral cancer cell migration and invasion by modulating p38 signaling pathway[J].Front Endocrinol(Lausanne),2020,30:568436.
[18] Ho JB,Kandhasamy S,Hyeon-Bae P,et al.Danshensu attenuates scopolamine and amyloid-β-induced cognitive impairments through the activation of PKA-CREB signaling in mice[J].Neurochem Int,2019,131:104537.
[19] Liu H,Zhang XY,Shao Y,et al.Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway[J].Bioengineered,2021,12(1):3113-3124.
[20] Sun HJ,Xiong SP,Cao X,et al.Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3[J].Redox Biol,2021,38:101813.

相似文献/References:

[1]王 钰,徐 琳,吕雅丽,等.扫描式葡萄糖监测系统在妊娠期糖尿病患者血糖管理中的应用[J].陕西医学杂志,2021,50(8):962.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.015]
　WANG Yu,XU Lin,LYU Yali,et al.Application of flash glucose monitoring in blood glucose management of pregnant women with gestational diabetes mellitus[J].,2021,50(5):962.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.015]
[2]杨 静,郭 永,郭润民.孕早期孕妇促甲状腺激素、甲状腺过氧化物酶抗体及微小RNA-873-5p水平与妊娠期糖尿病相关性研究[J].陕西医学杂志,2024,(4):479.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.009]
　YANG Jing,GUO Yong,GUO Runmin.Correlation between TSH,TPOAb,miR-873-5p levels in early pregnancy and gestational diabetes mellitus[J].,2024,(5):479.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.009]

备注/Memo

备注/Memo:
基金项目:河北省医学科学研究课题(20221769)
更新日期/Last Update: 2023-05-05